BAXTER HLTHCARE CORP FDA Approval ANDA 206916

ANDA 206916

BAXTER HLTHCARE CORP

FDA Drug Application

Application #206916

Application Sponsors

ANDA 206916BAXTER HLTHCARE CORP

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUSEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)0PALONOSETRON HYDROCHLORIDEPALONOSETRON HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-11-12STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

BAXTER HLTHCARE CORP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206916
            [companyName] => BAXTER HLTHCARE CORP
            [docInserts] => ["",""]
            [products] => [{"drugName":"PALONOSETRON HYDROCHLORIDE","activeIngredients":"PALONOSETRON HYDROCHLORIDE","strength":"EQ 0.25MG BASE\/5ML (EQ 0.05MG BASE\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/12\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-11-12
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.